News | RIVM

Improvement of air quality continues

In 2019, the calculated concentrations of nitrogen dioxide (NO2) and particulate matter (PM10) were below the European limit values in almost the whole of the Netherlands. Locally, the limit value for nitrogen dioxide is still being exceeded.

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Interim injunction decision Nitrogen

In an interim injunction proceeding between Mesdag Zuivelfonds, Stichting Stikstofclaim and RIVM, the court has ruled that RIVM must decide on the availability and disclosure of data before 1 Janua

A pregnant woman can protect her baby against whooping cough with 22-week vaccination

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

Exploratory RIVM calculations of nitrogen measures

The Dutch government announced its plans for the first steps in tackling the nitrogen deposition issue.

landschap met lanbouwgrond en bebouwing op de achtergrond

Openness about nitrogen

There is concern about the current approach to nitrogen and the proposed measures; these concerns have been expressed in Dutch society as a whole and amongst farmers in particular.

Graphit rain poses health risk

An assessment of potential health risks shows that graphite rain contains heavy metals and PAHs.

European critical loads: database, biodiversity and ecosystems at risk

Approximately 79 percent of the nature reserves (Natura 2000 areas) in EU countries are estimated to be exposed to an excess of nitrogen deposition in 2020.

Step forward in the battle against pertussis

Addition of an extra adjuvant (additive) to the current pertussis vaccines could enhance the effectivity of these vaccines.